Tiny silica nanoparticles engineered to seek out prostate cancer caused tumor cells to self-destruct and supercharged the immune system in preclinical mouse studies. Combined with immunotherapy, the treatment produced complete remissions in multiple mice, raising hopes for a powerful new approach to prostate cancer.
from Women's Health News -- ScienceDaily https://ift.tt/S0l7CsJ
0 comments:
Post a Comment